Advanced search
Publication Cover
Journal of Dermatological Treatment Volume 34, 2023 - Issue 1
Submit an article Journal homepage
789
Views
0
CrossRef citations to date
0
Altmetric
Letter to the Editor

Acrodermatitis continua of Hallopeau in an elderly patient successfully and rapidly treated with risankizumab: a case report

Diego Orsinia Clinical Dermatology Unit, IFO-San Gallicano Dermatological Institute-IRCCS, Rome, ItalyCorrespondence[email protected] [email protected]
View further author information
,
Paolo Iacovellia Clinical Dermatology Unit, IFO-San Gallicano Dermatological Institute-IRCCS, Rome, ItalyView further author information
,
Pasquale Frascioneb Oncologic and Preventive Dermatology Unit, IFO-San Gallicano Dermatological Institute-IRCCS, Rome, ItalyView further author information
&
Alessia Pacificoa Clinical Dermatology Unit, IFO-San Gallicano Dermatological Institute-IRCCS, Rome, ItalyView further author information
Article: 2229468 | Received 30 May 2023, Accepted 16 Jun 2023, Published online: 28 Jun 2023

References

  • Smith MP, Ly K, Thibodeaux Q, et al. Acrodermatitis continua of Hallopeau: clinical perspectives. Psoriasis (Auckl). 2019;9:1–3. doi: 10.2147/PTT.S180608.
  • Sehgal VN, Verma P, Sharma S, et al. Acrodermatitis continua of Hallopeau: evolution of treatment options. Int J Dermatol. 2011;50(10):1195–1211. doi: 10.1111/j.1365-4632.2011.04993.x.
  • Naldi L, Gambini D. The clinical spectrum of psoriasis. Clin Dermatol. 2007;25(6):510–518. doi: 10.1016/j.clindermatol.2007.08.003.
  • Chularojanamontri L, Rattanakorn K, Julanon N, et al. Acrodermatitis continua of Hallopeau and generalised pustular psoriasis: should they be the same or different entities? Exp Dermatol. 2023. Epub ahead of print. doi: 10.1111/exd.14805.
  • Sehgal VN, Sharma S. Significance of Gram’s stain smear, potassium hydroxide mount, culture, and microscopic pathology in the diagnosis of acrodermatitis continua of Hallopeau. Skinmed. 2011;9(4):260–261.
  • Menter A, Van Voorhees AS, Hsu S. Pustular psoriasis: a narrative review of recent developments in pathophysiology and therapeutic options. Dermatol Ther (Heidelb). 2021;11(6):1917–1929. doi: 10.1007/s13555-021-00612-x.
  • Orsini D, Gargiulo L, Ibba L, et al. Effectiveness of risankizumab in plaque psoriasis with involvement of difficult-to-treat areas: a real-world experience from two referral centers. J Dermatolog Treat. 2023;34(1):2220849. doi: 10.1080/09546634.2023.2220849.
  • Gargiulo L, Toso F, Ibba L, et al. Biologics for the treatment of severe acrodermatitis continua of hallopeau: report of two cases successfully treated with ixekizumab and ustekinumab. Dermatol Pract Concept. 2023;13(2):e2023103. doi: 10.5826/dpc.1302a103.
  • Narcisi A, Bernardini N, Orsini D, et al. Long-term safety and efficacy of adalimumab in psoriasis: a multicentric study focused on infections (connecting study). Postepy Dermatol Alergol. 2020;37(3):428–434. doi: 10.5114/ada.2020.96910.
  • Palacios-Álvarez I, Simal-Gómez G, Mas-Vidal A, et al. Treatment of acrodermatitis continua of Hallopeau with ustekinumab as monotherapy after failure of anti-TNF agents. J Dtsch Dermatol Ges. 2018;16(5):611–613. doi: 10.1111/ddg.13506.
  • Gokdemir G, Kutlu S, Köşlü A. Acrodermatitis continua resistant to etanercept: therapeutic challenge and unfortunate outcome. J Eur Acad Dermatol Venereol. 2009;23(3):345–347. doi: 10.1111/j.1468-3083.2008.02849.x.
  • Tobin AM, Kirby B. Successful treatment of recalcitrant acrodermatitis continua of Hallopeau with adalimumab and acitretin. Br J Dermatol. 2005;153(2):445–446. doi: 10.1111/j.1365-2133.2005.06759.x.
  • Ryan C, Collins P, Kirby B, et al. Treatment of acrodermatitis continua of Hallopeau with adalimumab. Br J Dermatol. 2009;160(1):203–205. doi: 10.1111/j.1365-2133.2008.08893.x.
  • Passante M, Dastoli S, Nisticò SP, et al. Effectiveness of brodalumab in acrodermatitis continua of Hallopeau: a case report. Dermatol Ther. 2020;33(1):e13170.
  • Miller AC, Holland TE, Cohen DJ. Treatment of acrodermatitis continua of hallopeau with ixekizumab. J Dermatolog Treat. 2021;32(1):117–119. doi: 10.1080/09546634.2019.1628170.
  • Schmid E, Mohr J, Schön MP, et al. Two cases of acrodermatitis continua suppurativa (Hallopeau’s disease) treated with IL-17A inhibitors. J Dtsch Dermatol Ges. 2019;17(6):643–645. doi: 10.1111/ddg.13857.
  • Langer N, Wilsmann-Theis D, Kromer C, et al. Successful therapy of acrodermatitis continua of Hallopeau with IL-23 blockers -two new cases. J Dtsch Dermatol Ges. 2021;19(10):1504–1507. doi: 10.1111/ddg.14586.
  • Hugo J, Gkalpakioti P, Arenbergerova M, et al. Acrodermatitis continua Hallopeau successfully treated by risankizumab. Int J Dermatol. 2021;60(4):e144–e145. doi: 10.1111/ijd.15391.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.